Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-15-004246
Filing Date
2015-09-09
Accepted
2015-09-09 16:30:35
Documents
13
Period of Report
2015-07-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tenx_10q.htm 10-Q 671734
2 AMENDED AND RESTATED BYLAWS tenx_ex31.htm EX-3.1 109534
3 DESCRIPTION OF NON-EMPLOYEE DIRECTOR COMPENSATION tenx_ex101.htm EX-10.1 6288
4 CERTIFICATION tenx_ex311.htm EX-31.1 13819
5 CERTIFICATION tenx_ex312.htm EX-31.2 13232
6 CERTIFICATION tenx_ex321.htm EX-32.1 7219
7 CERTIFICATION tenx_ex322.htm EX-32.2 8179
  Complete submission text file 0001354488-15-004246.txt   3004625

Data Files

Seq Description Document Type Size
8 tenx-20150731.xml EX-101.INS 608421
9 tenx-20150731.xsd EX-101.SCH 24781
10 tenx-20150731_cal.xml EX-101.CAL 36364
11 tenx-20150731_def.xml EX-101.DEF 34866
12 tenx-20150731_lab.xml EX-101.LAB 182874
13 tenx-20150731_pre.xml EX-101.PRE 130073
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Filer) CIK: 0000034956 (see all company filings)

EIN.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34600 | Film No.: 151099169
SIC: 8731 Services-Commercial Physical & Biological Research